Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr Eric Karran is a molecular biochemist by training, with a particular interest in enzymology and proteinases. He has spent most of his career in the pharmaceutical industry, leading and managing multi-disciplinary drug discovery teams. He has held Chief Scientific Officer and Vice President roles in a number of companies, including SmithKline Beecham (now GSK), Pfizer, Eli Lilly and Johnson and Johnson. During his career he has led and participated in a number of academic/industry collaborations. Eric has specialized in Neuroscience research, and particularly Alzheimer’s disease, for the past 20 years, participating in a number of projects that have led to late-stage clinical programmes. Eric is a Visiting Professor in the Department for Human Genetics at the Catholic University of Leuven, Belgium, and an Honorary Senior Research Associate in the Department of Molecular Neuroscience at the Institute of Neurology, University College London. He is currently the Director of Research for Alzheimer’s Research UK and has responsibility for setting the organization’s strategic scientific direction.
Dementia, Parkinson Disease, ALzheimer's Disease, Neurology, Advances in Alzheimers
Diane Stephenson, Martha Brumfield, Klaus Romero, Janet Woodcock, Issam Zineh, Eric M Reiman, Caroline Tanner, Richard Mohs, Walter Koroshetz, Timothy Nicholas, Lisa J Bain, Derek Hill, Les Shaw, Johan Luthman, Michael Ropacki, Richard Meibach, Peter Loupos, Ken Marek, James Hendrix, Eric Karran, George Vradenburg, Keiju Motohashi, Jesse M Cedarbaum and Mark Forrest Gordon
Conference Proceeding: J Alzheimers Dis Parkinsonism 2015, 5:183
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals